Kathleen Metters
Directors
Pharmaceutical
Pharmaxis
Australia
Biography
Dr Kathleen Metters joined the Board of Directors in June 2017 and was appointed to the Scientific Advisory Board in August 2017. Dr Metters brings more than 25 years of experience in the discovery and development of novel therapies for treatment of serious diseases and was formerly the Senior Vice President and Head of Worldwide Basic Research for Merck & Co. with oversight of all the company’s global research projects.
Research Interest
Molecular Biology
